RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault and other members of management will present a corporate overview of the Company and meet with investors at the Rodman & Renshaw 17th Annual Global Investment Conference in New York City. The presentation will take place on Thursday, September 10 at 2:10 PM EDT.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
